TP73 and urinary bladder carcinoma: In bladder cancer, the overexpression of TP73-AS1 suppresses epithelial–mesenchymal transition (EMT) by downregulating MMP-2 and MMP-9 expression while upregulating E-cadherin, thereby inhibiting tumor invasion and metastasis [17].